641 McKesson Corporation $MCK Shares Sold by Independent Advisor Alliance

Independent Advisor Alliance decreased its position in McKesson Corporation (NYSE:MCK – Free Report) by 18.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,890 shares of the company’s stock after selling 641 shares during the period. Independent Advisor Alliance’s holdings in McKesson were worth $2,732,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. OneAscent Financial Services LLC raised its position in McKesson by 3.2% in the third quarter. OneAscent Financial Services LLC now owns 841 shares of the company’s stock worth $718,000 after acquiring an additional 26 shares during the period. OneAscent Family Office LLC grew its stake in shares of McKesson by 32.8% during the 3rd quarter. OneAscent Family Office LLC now owns 620 shares of the company’s stock worth $529,000 after acquiring an additional 153 shares during the period. Meeder Asset Management Inc. raised its stake in McKesson by 28,360.0% in the 3rd quarter. Meeder Asset Management Inc. now owns 7,115 shares of the company’s stock valued at $6,075,000 after acquiring an additional 7,090 shares during the period. Composition Wealth LLC lifted its holdings in McKesson by 3.8% during the third quarter. Composition Wealth LLC now owns 2,011 shares of the company’s stock valued at $1,717,000 after purchasing an additional 74 shares during the last quarter. Finally, Muhlenkamp & Co. Inc. increased its stake in shares of McKesson by 0.3% in the third quarter. Muhlenkamp & Co. Inc. now owns 27,283 shares of the company’s stock worth $23,294,000 after purchasing an additional 81 shares in the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Stock Performance

NYSE:MCK opened at $1,062.62 on Friday. McKesson Corporation has a 52-week low of $723.68 and a 52-week high of $1,121.50. The stock has a fifty day moving average of $970.87 and a 200 day moving average of $879.62. The firm has a market capitalization of $122.69 billion, a price-to-earnings ratio of 27.32, a P/E/G ratio of 1.84 and a beta of 0.27.

McKesson (NYSE:MCK – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. The firm had revenue of $110.96 billion during the quarter, compared to the consensus estimate of $109.90 billion. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. The company’s revenue for the quarter was up 7.5% on a year-over-year basis. During the same quarter last year, the company posted $9.86 EPS. Equities analysts forecast that McKesson Corporation will post 46.09 earnings per share for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be issued a dividend of $0.94 per share. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Tuesday, December 1st. McKesson’s payout ratio is currently 9.67%.

Insiders Place Their Bets

In related news, EVP Francisco Fraga sold 650 shares of the company’s stock in a transaction on Thursday, November 5th. The shares were sold at an average price of $1,102.96, for a total value of $716,924.00. Following the completion of the transaction, the executive vice president directly owned 4,414 shares in the company, valued at approximately $4,868,465.44. The trade was a 12.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO B Jr sold 111 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total value of $98,950.95. Following the transaction, the chief accounting officer owned 521 shares in the company, valued at $464,445.45. This trade represents a 17.56% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,161 shares of company stock valued at $2,242,515 over the last ninety days. 0.06% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have issued reports on MCK shares. TD Cowen increased their target price on McKesson from $1,006.00 to $1,200.00 and gave the stock a “buy” rating in a research report on Thursday, November 5th. Argus raised their price target on McKesson from $850.00 to $970.00 and gave the stock a “buy” rating in a report on Thursday, September 3rd. UBS Group lifted their price target on McKesson from $1,200.00 to $1,250.00 and gave the company a “buy” rating in a research report on Thursday, November 5th. Barclays boosted their price objective on McKesson from $1,000.00 to $1,235.00 and gave the company an “overweight” rating in a research note on Wednesday. Finally, Citigroup increased their price objective on McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a report on Friday, July 24th. Fifteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $1,054.12.

View Our Latest Analysis on McKesson

About McKesson

(Free Report)

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.

Read More

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.